Company number: 04620455 Registered Charity: 1099537 European Society for Clinical Virology (Limited by guarantee) Report and Financial Statements for the year ended 31 October 2020 30/08/2021 Page 1 of 7 European Society for Clinical Virology (Limited by Guarantee) ## **Members of Executive - Company Directors (November 1[st] 2019 - October 31[st] 2020)** Prof. Dr. Mariet C.W. Feltkamp (President) Prof. Dr. Javier Buesa (Past President) Prof. Dr. Fausto Baldanti Prof. Dr. George Sourvinos Prof. Dr. Pamela Vallely (General Secretary) Prof. Dr. Heli Harvala Prof. Dr. Marcus Panning Prof. Dr. Maria São José Alexandre Nascimento ## **Company Secretary** Janina Ohnhaus, Kenes Group, Madrid Office Gema Casal, Kenes Group, Madrid Office Page 2 of 7 European Society for Clinical Virology (Limited by Guarantee) ## **European Society for Clinical Virology (ESCV) details** Registered Office Charles Darwin House 12 Roger Street London Company limited by guarantee N° 04620455 Registered as a Charity in England N° 1099537 Inland Revenue reference: 610 94961 19846 A 01 Page 3 of 7 European Society for Clinical Virology (Limited by Guarantee) ## **Directors’ Report** The European Society for Clinical Virology (ESCV) is a Company Limited by Guarantee, first incorporated in 2003. In accordance with the Society’s Memorandum of Association, each Company Member undertakes to contribute such amount as may be required, not exceeding £1, to the Company’s assets if it should be wound up while he or she is a Company Member or within one year after he or she ceases to be so. The Society is registered as a Charity, the Company Directors being the Charity’s Trustees. The Company Directors acting collectively are the Society’s Executive. The Executive hereby submits its report and financial statements for the year ending October 31[st] 2020. ## _**Organization and Objectives**_ According to the articles, the Society is administered by the Executive, made up of minimum three and maximum ten Company Directors/Charity Trustees. Currently the Executive numbers eight Directors. The ESCV has appointed a professional secretariat to handle administrative matters. This secretariat is Kenes Group, Calle Eraso, 36, 28028 Madrid, Spain In accordance with Article 4 the Executive admits as ‘ESCV Members’ such persons and subjects them to such rights and obligations as it thinks fit. Such ‘ESCV Members’ are not Company Members for the purposes of the Articles and are not entitled to vote on any matter save where expressly provided in the Articles. ESCV members of different European and other countries are represented by councilors, elected by each country’s members according to procedures described in the Articles. The councilors acting collectively are the Council. The Council elects the Company Directors/Charity Trustees according to procedures described in the Articles. The Society’s objectives are to promote public health and to advance public education, in particular medical education, by: - improving the knowledge of viruses, particularly as it relates to the diagnosis and management of viral diseases, their pathogenesis, natural history and prevention; - improving diagnostic methods; - promoting high standards in laboratory viral diagnosis through quality assessment activities and education; and - promoting or developing for the benefit of the public the preparation and exchange of reference reagents.” ## _**Reserves Policy**_ The Executive has the policy to maintain sufficient funds to allow the Society to meet its objectives and obligations on a long-term basis, and to provide a measure of investment income. It is the objective of the Society to utilize fully each year’s net income for its charitable activities. Page 4 of 7 European Society for Clinical Virology (Limited by Guarantee) ## _**Review of Activities in 2019/2020**_ ## **Scientific Meetings** - ESCV Workshop on Emerging Virus Infections, 23[rd] -24[th] January 2020, Vienna, Austria - ESCV Virtual Meeting on Covid-19, 9[th] September 2020 ## **Awards given at the ESCV 2020 Awards Ceremony (virtual)** - Gardner Lectureship Award 2020 by Prof. Marion Koopmans. - Abbott Award 2020 to Prof. Corinna Pietsch. - BioMerieux Award 2020 to Prof. Judith Breuer. ## **Travel grants and fellowships given** - 38 virologists received a travel grant to facilitate their attendance at the workshop in Vienna. - 1 virologist received a travel grant to facilitate her attendance at the ESCV congress in Copenhagen, Denmark. ## **Training grants** - None ## **Business Meetings held** - ESCV Executive Meetings were held on 22[nd] January 2020 and 6[th] October 2020 Page 5 of 7 European Society for Clinical Virology (Limited by Guarantee) ## **Future Scientific Meetings planned** - Award ceremony ESCV, 14[th] January 2021 - ESCV Virtual Spring Workshop – SARS-CoV-2 infection – laboratory response to pandemic, 22[nd] June 2021 - 23[rd] Annual Conference of the ESCV, 15[th] – 17[th] September 2021 (virtual) ------------------------------------------------------------ Signed on behalf of the Executive (Company Directors), Prof. Dr. Pam Vallely Company General Secretary Page 6 of 7 European Society lor Clinical Virology (Limited by Guarantee) Page7017 Company number: 04620455 Registered Charity: 1099537 European Society for Clinical Virology (Limited by guarantee) Report and Financial Statements for the year ended 31 October 2020 30/08/2021 Page 1 of 8 European Society for Clinical Virology (Limited by Guarantee) ## **Statement of financial activities (incorporating the income and expenditure account) Year ended 31 0ctober 2020** **----- Start of picture text -----**
Note Total 2020 £ Total 2019 Total 2018
£
£
Incoming Resources
Incoming resources from operating activities in furtherance of the Society’s
activities
Membership 1 £17,734 £4,931 £16,511
subscriptions (€20,605) (€5,505) (€18,350)
Sponsorship 2 £8,607 £8,958 £8998
(€10,000) (€10,000) (€10,000)
Meetings contributions 3 £72,994 £114,143 £92,672
(€84,810) (€127,424 (€102,994)
)
Investment Income
Income from listed 4 £0 £125 £602
investments (€0) (€139) (€669)
Total incoming resources £99,335 £128,157 £118,783
(€115,415) (€143,068 (€132,013)
)
Resources expended
Charitable expenditure
Grants payable in
furtherance of the 5 £27,509 £79,294 £43,585
Society’s (€31,961.75) (€88,520) (€48,440)
objects
Costs of activities in
furtherance of the
Society’s 6 £17,575 £57,025 £30,245
objects (€20,420.40) (€63,660) (€33,614)
Costs of management
& 7 £16,011 £17,371 £26,109
administration of the (€18,603.10) (€19,393 (€29,017)
Society )
Total resources expended £61,095 £151,653 £99,939
(€70,985.25) (€169,298 (€111,071)
)
Net incoming/outgoing £38,240 £-23,496 £18,844
resources for the year (€44,429.75) (€-26,230) (€20,941)
**----- End of picture text -----**
## European Society for Clinical Virology (Limited by Guarantee) **----- Start of picture text -----**
Other recognised gains
and £0 £0 -£5234
8
losses
Transfer between Funds - - -
Net movement in funds £38,240 £-23,496 £-18,844
for
(€44,429.75) (€-26,230) (€20,941)
the year
Fund balances carried £256,363 £228,660 £249,351
forward
(€297,860.46) (€255,264 (€282,941)
)
**----- End of picture text -----**
## **Balance Sheet** ## **31st October 2019** |**Current assets**
Cash at Bank & in Hand
9
Receivables
10
**Creditors: amounts falling**
**due**
**within one year**
Payables
11
**Net current assets**
**Society Funds**
General
**Total funds**
12|2020
2019
£
£
£256,363
(€297,860.4
6)
£228,660
(€255,26
4)
£-
£-
£256,363
£228,660
(€297,860.4
6)
(€255,26
4)
£-
£ -
£256,363
(€297,860.4
6)
£228,660
(€255,26
4)
£256,363
£228,660
(€297,860.4
6)
(€255,26
4)|2018
£
£249,351
(€282,941)
£-| |---|---|---| |||£249,351| |||(€282,941)
£ -| |||£249,351
(€282,941)| |||| |||£249,351| |||(€282,941)| The notes on pages 10 to 12 form part of these financial statements European Society for Clinical Virology (Limited by Guarantee) European Society for Clinical Virology (Limited by Guarantee) ## **Audit Exemption** (a) For the year ended 31 October 2018 the company was entitled to exemption from audit under section 477(2) of the Companies Act 2006 relating to small companies. (b) Members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006. (c) The directors acknowledge their responsibility for: i. ensuring the company keeps accounting records which comply with section 386; and ii. preparing accounts which give a true and fair view of the state of affairs of the company as at the end of the financial year, and of its profit or loss for the financial year, in accordance with the requirements of section 393, and which otherwise comply with the requirements of the Companies Act relating to accounts, so far as applicable to the company; (d) These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies’ regime. **Approved by Executive on 27[th] May 2021 and signed on its behalf by Prof. Dr. Pam Vallely (company General Secretary ESCV)** Prof. Pamela Vallely **Member of Executive** European Society for Clinical Virology (Limited by Guarantee) ## **Notes to the Financial Statements** |1. Membership Subscriptions|1. Membership Subscriptions|£ 12,945 15,040 €
£ 4,789
5,565 €
**£ 17,734**
**20,605**
**€**
£
2,152
2,500 €
£
6,455
7,500 €
**£**
**8,607**
**10,000**
**€**
**£**
**72,994**
**84,810**
**€**
£
0
0 €
£ 16,520
19,194.15 €
£ 661
767.60 €
**£**
**17,181**
**19,961.75**
**€**
£ 2,152
2,500 €
£ 1,721
2,000 €
£ 6,455
7,500 €
£ 0
0 €
**£**
**10,328**
**12,000 €**
**£**
**27,509**
**31,961.75**
**€**|£ 12,945 15,040 €
£ 4,789
5,565 €
**£ 17,734**
**20,605**
**€**
£
2,152
2,500 €
£
6,455
7,500 €
**£**
**8,607**
**10,000**
**€**
**£**
**72,994**
**84,810**
**€**
£
0
0 €
£ 16,520
19,194.15 €
£ 661
767.60 €
**£**
**17,181**
**19,961.75**
**€**
£ 2,152
2,500 €
£ 1,721
2,000 €
£ 6,455
7,500 €
£ 0
0 €
**£**
**10,328**
**12,000 €**
**£**
**27,509**
**31,961.75**
**€**|£ 12,945 15,040 €
£ 4,789
5,565 €
**£ 17,734**
**20,605**
**€**
£
2,152
2,500 €
£
6,455
7,500 €
**£**
**8,607**
**10,000**
**€**
**£**
**72,994**
**84,810**
**€**
£
0
0 €
£ 16,520
19,194.15 €
£ 661
767.60 €
**£**
**17,181**
**19,961.75**
**€**
£ 2,152
2,500 €
£ 1,721
2,000 €
£ 6,455
7,500 €
£ 0
0 €
**£**
**10,328**
**12,000 €**
**£**
**27,509**
**31,961.75**
**€**| |---|---|---|---|---| ||Society Membership subscriptions|||| ||OptionalJCV subscriptions|||| ||**Total**|||| |||||| |||||| |2. Sponsorship||||| ||Sponsorship income was received for:|||| ||Abbott|||| ||BioMérieux|||| ||**Total**|||| |||||| |3. Meetings Contributions||||| |VM Congresses – 22ndAnnual Congress ESCV||||| |||||| |4. Return on investments||||| |General||||| |||||| |5. Grants and awards||||| ||Travel grants to recipients|||| ||
Viena|||| ||Copenhagen|£ 661||| ||**Total**|**£**
**17,181**||| ||Training Grants|||| ||
Abbott Diagnostics Awards|£ 2,152||| ||Heine-Medin Award|£ 1,721||| ||BioMérieux Award|£ 6,455||| ||Gardner Award|£ 0||0 €| ||**Total**|**£**
**10,328**||| ||**TOTAL**|**£**
**27,509**||| |||||| |6. Costs of Activities in furtherance of the objectives of
the Society||||| |Purchase of Journal of Clinical Virology||£ 1,784||2,072.38 €| European Society for Clinical Virology (Limited by Guarantee) ||Expenses of lecturers & venues at Scientifc meetings|Expenses of lecturers & venues at Scientifc meetings|£|15,791||18,348.02 €| |---|---|---|---|---|---|---| ||||**£**|||**20,420.40**| ||||**17,575**|||**€**| |7. Management and administration of the Society||||||| ||Administration costs||£|11,247||13,068 €| ||Postal and Communications||£|-||0 €| ||Executive travel and accommodation||£|4,260||4,949.58 €| ||Other||£|-||0 €| ||Bank charges||£|504||585.52 €| ||||**£**|||**18,603.10**| ||||**16,011**|||**€**| |8. Other Gains and Losses||||£|-|
0 €| |9. Bank & Cash as at 31st October 2019||||||| ||||£|||| ||BBVA Bank||256,363|||297,860.46 €| |10. Receivables||||||| ||**TOTAL**||**£**|**-**||**- €**| |11. Payables||||||| ||**TOTAL**|**£**||**-**||**- €**| |12. Analysis of Net Assets between Reserves||||||| ||General in bank||£|-||0 €| ||||£|||| ||Creditors||256,363|||297,860.46 €| ||||**£**|||| |**TOTAL**|||**256,363**||**297,860.46 €**|| European Society for Clinical Virology (Limited by Guarantee) This page is left blanc intentionally (last pagel CHARITY COMMISSION FOR ENGLAND AND WALES Independent examiner's report on the accounts Section A Independent Examinerfs Report Report to the trusteesl members of European Society for Clinical Virology On ac¢ounts for the year ended 31. October 2020 Charity no (If anyl 1099537 Set out on pages L pages I report to the trustees on my examination of the accounts of the above charity I'the Trusl") for the year ended 3111012020. Responslblllties and As the charity trustees of the Trust, you are responsible for the preparation basls of report cf the arKounls in accordance with the requirements of the Charities A 011 ('the Act'}. I report in respect of my examination of the Trust's accounts carried out Lnder section 145 of the 2011 Acl and in Carrying out my examination, I Tave followed the applicable Directions given by the Charity Commlssion under section 145(51{b} of the Act. I have completed my examination. I confirm that no material matters have come to my attention (other than that disclosed below "l in connection with the examination which gives me cause to believe that in, any material respect.. accounting records We￿ not kept in accordance with section 130 of Ihe Act or the accounts do not accord with the accounting reGords Independent examiner's statsment I have no cOn￿rn$ and have come across no other matters in connection with Ihe examination to which attention should be drawn in order to enable a proper understanding of the accounts to be reached. Please d81ete the words in tha brackets if they do not apply. Signed: Date: 21.07.2021 Name: usanne G. Dudman Relevant profossional qualificatlon{sl or body (if any): enior Medic81 Officer Address: Oslo University Hospital P.O.Box 4950 Nydalen 0424 Oslo, Norway IER October 2018 Section B Disclosure Only complete if the examiner needs to highlight matters of concern (see CC32, Independent examination of charity accounts.. directions and guidance for examiners). Give here brief details of any items that the examiner wishes to disclose. Nothing to disclose. IER October 2018